These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 38671465

  • 1. Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease.
    Mahboobipour AA, Ala M, Safdari Lord J, Yaghoobi A.
    Orphanet J Rare Dis; 2024 Apr 26; 19(1):175. PubMed ID: 38671465
    [Abstract] [Full Text] [Related]

  • 2. Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease.
    Masyuk T, Masyuk A, Trussoni C, Howard B, Ding J, Huang B, LaRusso N.
    JHEP Rep; 2021 Oct 26; 3(5):100345. PubMed ID: 34568801
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Modelling polycystic liver disease progression using age-adjusted liver volumes and targeted mutational analysis.
    Sierks D, Schönauer R, Friedrich A, Hantmann E, de Fallois J, Linder N, Fischer J, Herber A, Bergmann C, Berg T, Halbritter J.
    JHEP Rep; 2022 Nov 26; 4(11):100579. PubMed ID: 36246085
    [Abstract] [Full Text] [Related]

  • 6.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Harris PC, Torres VE.
    ; 1993 Nov 26. PubMed ID: 20301424
    [Abstract] [Full Text] [Related]

  • 7. Genetic Spectrum of Polycystic Kidney and Liver Diseases and the Resulting Phenotypes.
    Yang H, Sieben CJ, Schauer RS, Harris PC.
    Adv Kidney Dis Health; 2023 Sep 26; 30(5):397-406. PubMed ID: 38097330
    [Abstract] [Full Text] [Related]

  • 8. Cilia and polycystic kidney disease.
    Ma M.
    Semin Cell Dev Biol; 2021 Feb 26; 110():139-148. PubMed ID: 32475690
    [Abstract] [Full Text] [Related]

  • 9. Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling.
    Wills ES, Te Morsche RHM, van Reeuwijk J, Horn N, Geomini I, van de Laarschot LFM, Mans DA, Ueffing M, Boldt K, Drenth JPH, Roepman R.
    Hum Mol Genet; 2017 Nov 01; 26(21):4190-4202. PubMed ID: 28973524
    [Abstract] [Full Text] [Related]

  • 10. Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing.
    Lanktree MB, Haghighi A, Guiard E, Iliuta IA, Song X, Harris PC, Paterson AD, Pei Y.
    J Am Soc Nephrol; 2018 Oct 01; 29(10):2593-2600. PubMed ID: 30135240
    [Abstract] [Full Text] [Related]

  • 11. Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management.
    Cnossen WR, Drenth JP.
    Orphanet J Rare Dis; 2014 May 01; 9():69. PubMed ID: 24886261
    [Abstract] [Full Text] [Related]

  • 12. Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.
    Cornec-Le Gall E, Torres VE, Harris PC.
    J Am Soc Nephrol; 2018 Jan 01; 29(1):13-23. PubMed ID: 29038287
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Polycystic Liver Disease: Advances in Understanding and Treatment.
    Masyuk TV, Masyuk AI, LaRusso NF.
    Annu Rev Pathol; 2022 Jan 24; 17():251-269. PubMed ID: 34724412
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic Targets in Polycystic Liver Disease.
    Masyuk TV, Masyuk AI, LaRusso NF.
    Curr Drug Targets; 2017 Jan 24; 18(8):950-957. PubMed ID: 25915482
    [Abstract] [Full Text] [Related]

  • 16. Genetics of polycystic liver diseases.
    Lee-Law PY, van de Laarschot LFM, Banales JM, Drenth JPH.
    Curr Opin Gastroenterol; 2019 Mar 24; 35(2):65-72. PubMed ID: 30652979
    [Abstract] [Full Text] [Related]

  • 17. Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease.
    Boerrigter MM, Duijzer R, Te Morsche RHM, Drenth JPH.
    Genes (Basel); 2023 Sep 02; 14(9):. PubMed ID: 37761895
    [Abstract] [Full Text] [Related]

  • 18. ALG9 Mutation Carriers Develop Kidney and Liver Cysts.
    Besse W, Chang AR, Luo JZ, Triffo WJ, Moore BS, Gulati A, Hartzel DN, Mane S, Regeneron Genetics Center, Torres VE, Somlo S, Mirshahi T.
    J Am Soc Nephrol; 2019 Nov 02; 30(11):2091-2102. PubMed ID: 31395617
    [Abstract] [Full Text] [Related]

  • 19. New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney disease.
    Barten TRM, Bernts LHP, Drenth JPH, Gevers TJG.
    Expert Opin Ther Targets; 2020 Jun 02; 24(6):589-599. PubMed ID: 32250187
    [Abstract] [Full Text] [Related]

  • 20. Molecular Mechanisms of Isolated Polycystic Liver Diseases.
    Yu Z, Shen X, Hu C, Zeng J, Wang A, Chen J.
    Front Genet; 2022 Jun 02; 13():846877. PubMed ID: 35571028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.